Drugs / Piper crocatum
last change Apr 2023 re-read 2 minutes ago

Piper crocatum

Developed for
anogenital human papillomavirus infection
Investigated by
Hasanuddin University

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05622916 Nov 2022 → Feb 2023 anogenital human papillomavirus infection Hasanuddin University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Piper crocatum ClinicalTrials.gov intervention name — accepted as the source's own label NCT05622916
Route Topical “Daily topical application (twice/day, in the morning and 30-60 minutes before bed at night) for 56 days.” NCT05622916